Compare Cronos Group Inc (CRON) vs Novo Nordisk A/S (NVO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cronos Group Inc vs Novo Nordisk A/S — how do they compare? Cronos Group Inc trades at $3.08 (market cap $1.14B), while Novo Nordisk A/S trades at $45.9 (market cap $207.85B). The key difference: Novo Nordisk A/S is far larger — about 182.3× Cronos Group Inc's market cap, and Novo Nordisk A/S pays a 3.81% dividend while Cronos Group Inc pays none. Which is the better fit depends on your goals.
| CRON | NVO | |
|---|---|---|
Market Cap | $1.14B | $207.85B |
Sector | Health | Health |
52-Week High | $3.27 | $63.98 |
52-Week Low | $2.30 | $35.29 |
Enterprise Value | $341.13M | $222.55B |
Dividend Yield | — | 3.81% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Cronos Group Inc
Cronos Group, headquartered in Toronto, Canada cultivates and sells medicinal and recreational cannabis through its medicinal brand, Peace Naturals, and its two recreational brands, Cove and Spinach. Although it primarily operates in Canada, Cronos exports medical cannabis to Poland and Germany. In addition, it has entered joint ventures in Israel, Colombia, and Australia to drive further international cultivation and distribution growth. In the U.S. the company directly sells hemp-derived CBD and has an option to acquire 10.5% of U.S. multistate operator PharmaCann.
Read more on CRON →About Novo Nordisk A/S
With almost 50% market share by volume of the global insulin market, Novo Nordisk is the leading provider of diabetes-care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments, and oral antidiabetic agents. Novo also has a biopharmaceutical segment (constituting roughly 15% of revenue) that specializes in protein therapies for hemophilia and other disorders.
Read more on NVO →
